Holen Sie sich die Stockscreener-App
3.66
11.93%
0.39
Handel nachbörslich:
3.74
0.08
+2.19%
Schlusskurs vom Vortag:
$3.27
Offen:
$3.24
24-Stunden-Volumen:
196.27K
Relative Volume:
2.45
Marktkapitalisierung:
$51.59M
Einnahmen:
$19.91M
Nettoeinkommen (Verlust:
$-127.11M
KGV:
-4.6959
EPS:
-0.7794
Netto-Cashflow:
$-132.44M
1W Leistung:
+9.25%
1M Leistung:
+14.02%
6M Leistung:
-32.47%
1J Leistung:
+0.33%
1-Tages-Spanne:
$3.24
$3.7199
1-Wochen-Bereich:
$3.159
$3.7199
52-Wochen-Spanne:
$2.9178
$8.95
Affimed N V Stock (AFMD) Company Profile
Affimed N V Stock (AFMD) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2022-12-12 | Eingeleitet | H.C. Wainwright | Buy |
| 2022-10-10 | Herabstufung | Stifel | Buy → Hold |
| 2022-08-18 | Fortgesetzt | Wells Fargo | Overweight |
| 2022-03-31 | Eingeleitet | Piper Sandler | Overweight |
| 2022-02-23 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2021-10-21 | Eingeleitet | Truist | Buy |
| 2021-09-30 | Eingeleitet | Stifel | Buy |
| 2021-03-31 | Eingeleitet | Credit Suisse | Outperform |
| 2019-03-28 | Eingeleitet | SVB Leerink | Outperform |
| 2018-08-28 | Hochstufung | Jefferies | Hold → Buy |
| 2017-07-14 | Eingeleitet | SunTrust | Buy |
| 2016-08-12 | Herabstufung | Leerink Partners | Outperform → Mkt Perform |
| 2016-05-19 | Herabstufung | Leerink Partners | Outperform → Mkt Perform |
| 2015-12-10 | Eingeleitet | Laidlaw | Buy |
| 2015-12-04 | Eingeleitet | Wells Fargo | Outperform |
| 2015-09-09 | Eingeleitet | Jefferies | Hold |
| 2015-08-06 | Bestätigt | Oppenheimer | Outperform |
| 2015-06-22 | Bestätigt | Jefferies | Buy |
Alle ansehen
Affimed N V Aktie (AFMD) Neueste Nachrichten
Affimed Announces Acceptance of Three Abstracts at the 2024 - GlobeNewswire
Affimed N.V. Announces Acceptance of Three Abstracts At the 2024 Ash Annual Meeting Including an Oral Presentation Underscoring Advancing Clinical Pipeline in Leukemia and Lymphoma - Marketscreener.com
Affimed (NASDAQ:AFMD) Receives Consensus Rating of "Buy" from Brokerages - MarketBeat
Affimed (NASDAQ:AFMD) Given Average Rating of “Buy” by Analysts - Defense World
Affimed (NASDAQ:AFMD) Short Interest Update - MarketBeat
683 Capital Management, LLC Expands Stake in Affimed NV - Yahoo Finance
Affimed Appoints New Director Amid Strategic Moves - TipRanks
Affimed N : Annual General Meeting Results Form 6 K - Marketscreener.com
Affimed N : Presentation - Marketscreener.com
Analysts Set Affimed (NASDAQ:AFMD) Target Price at $20.00 - MarketBeat
Affimed Appoints New CEO, Shares Fall on Leadership Change - MSN
Affimed appoints Shawn Leland as chief executive officer - MSN
Affimed (NASDAQ:AFMD) Sees Significant Decrease in Short Interest - MarketBeat
AFMDAffimed N.V. Latest Stock News & Market Updates - StockTitan
Affimed N.V. Announces Upcoming EGM - TipRanks
Affimed to Present at the Cantor Global Healthcare Conference 2024 - GlobeNewswire
Affimed (NASDAQ:AFMD) Receives “Overweight” Rating from Cantor Fitzgerald - Defense World
Cantor Fitzgerald Reiterates "Overweight" Rating for Affimed (NASDAQ:AFMD) - MarketBeat
Affimed (NASDAQ:AFMD) Receives Consensus Rating of "Buy" from Analysts - MarketBeat
Affimed N.V. (NASDAQ:AFMD) Q2 2024 Earnings Call Transcript - Insider Monkey
HC Wainwright Reaffirms Buy Rating for Affimed (NASDAQ:AFMD) - MarketBeat
Earnings call: Affimed reports promising clinical results and stable finances By Investing.com - Investing.com Australia
Earnings call: Affimed reports promising clinical results and stable finances - Investing.com
Affimed NV (AFMD) Q2 2024 Earnings Call Transcript Highlights: F - GuruFocus.com
Affimed N.V.: Q2 Earnings Snapshot - New Haven Register
Affimed to Present Preclinical Data Demonstrating Cytotoxic Activity of its Novel Innate Cell Engager AFM28 at the Annual Meeting of the European Hematology Association (EHA) - Yahoo Finance UK
Stifel holds Affimed at $5 target with new CEO at helm By Investing.com - Investing.com Canada
Stifel holds Affimed at $5 target with new CEO at helm - Investing.com
Affimed Appoints Shawn M. Leland as Chief Executive Officer - Yahoo Finance UK
Affimed Reports Second Quarter 2024 Financial Results & Business Update - Yahoo Finance UK
Affimed NV reports results for the quarter ended in June 30Earnings Summary - xm.com
Affimed reports Q2 EPS (EUR1.01) vs. (EUR1.97) last year - TipRanks
Affimed N.V. Faces Substantial Mid-Year Losses - TipRanks
Affimed N.V.: Q2 Earnings Snapshot | National Business News | voiceofalexandria.com - Voice Of Alexandria
Affimed Follow Up: Upcoming Acimtamig And AFM24 Updates Could Be Positive Catalysts - Seeking Alpha
Affimed NV (AFMD) Q2 2024 Earnings Report Preview: What To Look For - GuruFocus.com
Affimed names Shawn Leland as new CEO By Investing.com - Investing.com Canada
Affimed appoints Shawn Leland as Chief Executive Officer - TipRanks
Affimed Appoints New CEO to Bolster Growth - TipRanks
Affimed names Shawn Leland as new CEO - Investing.com
Affimed (AFMD) Set to Announce Quarterly Earnings on Thursday - MarketBeat
Affimed to Report Second Quarter 2024 Financial Results & Corporate Update on September 5, 2024 - GlobeNewswire
Affimed (NASDAQ:AFMD) Stock Price Crosses Below 200 Day Moving Average of $5.35 - Defense World
Affimed (NASDAQ:AFMD) Stock Crosses Below 200 Day Moving Average of $5.35 - MarketBeat
Finanzdaten der Affimed N V-Aktie (AFMD)
Umsatz
Nettogewinn
Free Cashflow
ENV
2.02%
0.47%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Kapitalisierung:
|
Volumen (24h):